Hester Biosciences consolidated net profit rises 8.01% in the June 2024 quarter
Net profit of Hester Biosciences rose 8.01% to Rs 6.34 crore in the quarter ended June 2024 as against Rs 5.87 crore during the previous quarter ended June 2023. Sales declined 6.35% to Rs 82.27 crore in the quarter ended June 2024 as against Rs 87.85 crore during the previous quarter ended June 2023.
Particulars | Quarter Ended | ||
Jun. 2024 | Jun. 2023 | % Var. | |
Sales | 82.27 | 87.85 | -6 |
OPM % | 21.45 | 16.35 | - |
PBDT | 14.73 | 14.31 | 3 |
PBT | 10.59 | 8.91 | 19 |
NP | 6.34 | 5.87 | 8 |

Biggest Winners and Losers in MSCI: Key Movers in Global Indices 2025
3 mins read . Aug 20, 2025

What MF Big Boys Bought and Sold – Top Mutual Fund Stock Activity in 2025
8 mins read . Aug 18, 2025

10 Financial Planning Checklist For 2025
7 mins read . Aug 12, 2025

Explore our products
Unlimited Trading starting at ₹249 ₹0
Open Trading Account
Recent Article
- •
- •
- •
- •